The Effect of Intratracheal Furosemide, Salbutamol, or a Mixture of Both with Surfactant on Clinical Course of Neonatal Respiratory Distress Syndrome

Phase 2

• Conditions: P00-P96; Respiratory Distress Syndrome.; certain conditions originating in the perinatal period

• Registration Number: IRCT2014072714215N1
• Lead Sponsor: Ahvaz Jundishapur University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

newborns with gestational less than 34 weeks; respiratory distress syndrome and Exclusion criteria: birth weight less than 1000gr; birth trauma; congenital anomalies; birth asphyxia; transported patients

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical course. Timepoint: Discharge from hospital. Method of measurement: Hours and days that patients needing to respiratory therapy.

Secondary Outcome Measures

Name	Time	Method
Death. Timepoint: Cardiorespiratory arrest. Method of measurement: Absent of heart beat and respiratory movement.